Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases. A crucial step toward their successful clinical application is to examine the immune response that might be launched against them after transplantation. We used two experimental platforms to examine the in vivo leukocyte response toward hESCs. First, immunocompetent and immunodeficient mouse strains were used to identify T cells as the major component that causes xenorejection of hESCs. Second, mice that were conditioned to carry peripheral blood leukocytes from human origin were used to test the human leukocyte alloresponse toward undifferentiated and differentiated hESCs. Using this model, we have detected only a minute immune response toward undifferentiated as well as differentiated hESCs over the course of 1 month, although control adult grafts were repeatedly infiltrated with lymphocytes and destroyed. Our data show that the cells evade immune destruction due to a low immunostimulatory potential. Nevertheless, a human cytotoxic T lymphocyte clone that was specifically prepared to recognize two hESC lines could lyse the cells after major histocompatibility complex class I (MHC-I) induction. Although MHC-I levels in hESCs are sufficient for rejection by cytotoxic T cells, our data suggest that the immunostimulatory capacity of the cells is very low. Thus, immunosuppressive regimens for hESC-based therapeutics could be highly reduced compared with conventional organ transplantation because direct allorejection processes of hESCs and their derivatives are considerably weaker.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although most of the pluripotent stem cells have low HLA expression [93], iPSC derivatives can trigger an immune response.”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [93]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A., & Bongso, A. (2000) · Nature Biotechnology · doi:10.1038/74447 · Cited by 2,706
In vitro differentiation of transplantable neural precursors from human embryonic stem cells
Zhang, S.-C., Wernig, M., Duncan, I. D., Brüstle, O., & Thomson, J. A. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1129 · Cited by 1,912
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H., & Benvenisty, N. (2000) · Molecular Medicine · doi:10.1007/bf03401776 · Cited by 1,500
Self-citationPrognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Schuldiner, M., Yanuka, O., Itskovitz-Eldor, J., Melton, D. A., & Benvenisty, N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11307 · Cited by 1,134
Self-citationNeural progenitors from human embryonic stem cells
Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., & Ben-Hur, T. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1134 · Cited by 1,119
Cited by
Items 201–300 of 403
Anti-HLA antibodies in regenerative medicine stem cell therapy
Charron, D. J., Suberbielle, C., Tamouza, R., & Al‐Daccak, R. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.06.010 · Cited by 20
Trigona, W. L., Porter, C. M., Horvath‐Arcidiacono, J. A., Majumdar, A. S., & Bloom, E. T. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1602 · Cited by 19
“There is a growing body of literature providing contradictory evidence regarding whether ESC stimulate an immune response or are immune privileged (17, 28) or even immunosuppressive (10, 11, 19).”
InfluentialAllogenicity & immunogenicity in regenerative stem cell therapy.
Charron, D. J. (2013) · PubMed Central · Cited by 18
Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines
de Jesus, B. B., Neves, B. M., Ferreira, M. M., & Pereira, S. N. (2020) · Cancers · doi:10.3390/cancers12123581 · Cited by 19
“As undifferentiated ESCs express low levels of MHC-I and co-stimulatory molecules, transplanted graft-derived antigens may be processed directly by APCs or indirectly through APCs activation of T cells [129,138,139].”
BackgroundLaryngeal mask airway insertion anaesthesia and insertion techniques.
Monem, A., & Khan, F. A. (2007) · PubMed · Cited by 18
Toriumi, H., Yoshikawa, M., Matsuda, R., Nishimura, F., Yamada, S., Hirabayashi, H., Nakase, H., Nonaka, J.-I., Ouji, Y., Ishizaka, S., et al. (2009) · Neurological Research · doi:10.1179/016164108x339378 · Cited by 18
Lampton, P. W., Crooker, R. J., Newmark, J. A., & Warner, C. M. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01132.x · Cited by 18
Chhabra, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00993 · Cited by 15
“Furthermore, these iPSC lines do not express MHC class II molecules but do express low levels of MHC class I molecules (14), in agreement with findings in hESC lines (13, 33, 42).”
BackgroundResultInfluentialIs Xenotransplantation of Embryonic Stem Cells a Realistic Option?
Bonnevie, L., Bel, A., Sabbah, L., Al‐Attar, N., Pradeau, P., Weill, B. J., Deist, F. L., Bellamy, V., Peyrard, S. V., nard, C. M., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000247798.68218.29 · Cited by 18
“Furthermore, although the immunostimulatory capacity of these cells may be attenuated in an allogeneic setting (7), it is increasingly apparent that as long as somatic cell nuclear transfer remains hypothetical, the clinical use of ESC will require the closest donor–recipient HLA matching completed by some form of imm…”
BackgroundChallenges for the Therapeutic use of Pluripotent Stem Derived Cells
Forsberg, M., & Hovatta, O. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00019 · Cited by 17
“Findings are that undifferentiated cells express MHC I antigens, though at low levels compared with somatic cells; but they do not express MHC II molecules (Drukker et al., 2002, 2006; Li et al., 2004).”
BackgroundSafe Transplantation Of Pluripotent Stem Cell By Preventing Teratoma Formation
Mohseni, R. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000212 · Cited by 17
Kim, A., Lee, K., Kwon, Y., Lee, K.-I., Yang, H.-M., Habib, O., Kim, J., Kim, S. J., Kim, J., Kim, J., et al. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10113-7 · Cited by 17
Zhu, M., Wan, W., Li, H.-S., Wang, J., Chen, G., & Ke, X. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.12.012 · Cited by 19
Myocardial regeneration by embryonic stem cell transplantation: present and future trends
Dai, W., & Kloner, R. A. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.3.375 · Cited by 17
Rosenblatt‐Velin, N., Badoux, S., & Liaudet, L. (2016) · Stem Cells International · doi:10.1155/2016/5961342 · Cited by 17
“…the human embryonic stem cells express constitutively the HLA proteins at low levels, when stimulated with interferon gamma or fibroblast growth factor 2 (FGF-2), both cell types increased HLA protein expressions, which render these cells able to be rejected rapidly on transplantation [106–110].”
Beneath The Sword Of Damocles: Regenerative Medicine And The Shadow Of Immunogenicity
Fairchild, P. J., Horton, C. G., Lahiri, P., Shanmugarajah, K., & Davies, T. J. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0134 · Cited by 18
McClellan, A., Paterson, Y. Z., Paillot, R., & Guest, D. J. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0120 · Cited by 17
Cardiac Repair and Restoration Using Human Embryonic Stem Cells
Bernstein, H. S. (2012) · Regenerative Medicine · doi:10.2217/rme.12.46 · Cited by 17
Archibald, P., & Williams, D. (2015) · Regenerative Medicine · doi:10.2217/rme.15.59 · Cited by 17
Human Dendritic Cell–Derived Induced Pluripotent Stem Cell Lines Are Not Immunogenic
Chhabra, A., Chen, I., & Batra, D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601676 · Cited by 16
“molecules (18), exhibit immune-privileged properties (19, 20), and are rejected in immune-competent mice through a T cell– mediated allograft-rejection process (19, 21, 22); however, the inherent immunogenicity of human iPSC lines has not been examined carefully.”
BackgroundГордеева, О. Ф., & Khaydukov, S. (2017) · Stem Cells International · doi:10.1155/2017/7284872 · Cited by 19
Yoshinaga, Y., Soma, T., Azuma, S., Maruyama, K., Hashikawa, Y., Katayama, T., Sasamoto, Y., Takayanagi, H., Hosen, N., Shiina, T., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.018 · Cited by 16
Park, K., Cha, S., Ahn, C., & Woo, H. (2013) · Veterinary Research Communications · doi:10.1007/s11259-013-9574-x · Cited by 18
“Pretreatment with IFN-γ could be a possible strategy to reduce cytolysis by autologous NK cells and therefore increase MHC expression of transplanted cells (Boyd and Wood 2009; Drukker et al. 2002).”
BackgroundLow immunogenicity of endothelial derivatives from rat embryonic stem cell-like cells
Ladhoff, J., Bäder, M., Brösel, S., Effenberger, E., Westermann, D., Volk, H., & Seifert, M. (2009) · Cell Research · doi:10.1038/cr.2009.21 · Cited by 16
Stem cells: new frontiers of ethics, law, and policy
Scott, C. T. (2008) · Neurosurgical FOCUS · doi:10.3171/foc/2008/24/3-4/e23 · Cited by 16
Regenerating the heart using human embryonic stem cells--from cell to bedside.
Caspi, O., & Gepstein, L. (2006) · PubMed · Cited by 16
Transplanted embryonic retinal stem cells have the potential to repair the injured retina in mice
Feng, X., Chen, P., Zhao, X., Wang, J., & Wang, H. (2021) · BMC Ophthalmology · doi:10.1186/s12886-020-01795-1 · Cited by 15
Stem Cells: Current Approach and Future Prospects in Spinal Cord Injury Repair
Zhang, N., Wimmer, J., Qian, S., & Chen, W. (2009) · The Anatomical Record · doi:10.1002/ar.21025 · Cited by 15
“It also showed the reliable long-term survival of grafts derived from porcine expanded neural precursors in a rat model, with maturation and integration into the host brain (El-Badri et al., 2006; Harrower et al., 2006).”
BackgroundLondoño, R., Gorantla, V. S., & Badylak, S. F. (2015) · Stem Cells International · doi:10.1155/2016/1541823 · Cited by 18
“On the other hand, active immunomodulation [42, 44, 50–52] has been shown to be the result of both ligand-mediated [42, 50] and soluble factor-mediated [53, 54] processes.”
Pluripotent stem cells and tolerance induction in organ transplantation
Imberti, B., Monti, M., & Casiraghi, F. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000144 · Cited by 15
Hemodynamic Forces Regulate Embryonic Stem Cell Commitment to Vascular Progenitors
Hsiai, T. K., & Wu, J. C. (2008) · Current Cardiology Reviews · doi:10.2174/157340308786349471 · Cited by 15
“Multiple markers have been used to characterize the vascular-endothelial differentiation capabilities of human ES cells (Fig.”
Gould, M. L., Downes, N., Woolley, A. G., Hussaini, H. M., Ratnayake, J. T., Ali, A., Friedlander, L. T., & Cooper, P. R. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202400254 · Cited by 14
Dong, W., Qiu, C., Shen, H., Liu, Q., & Du, J. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.6538 · Cited by 14
“Now it has been well proved that ESCs and their derivatives could generate effective cellular immune response and active CD4+ and CD8+ lymphocytes [22-24].”
BackgroundEpigenetics of Embryonic Stem Cells
Calvanese, V., & Fraga, M. F. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2098-9_16 · Cited by 15
Use of regenerative tissue for urinary diversion
Sopko, N. A., Kates, M. R., & Bivalacqua, T. J. (2015) · Current Opinion in Urology · doi:10.1097/mou.0000000000000223 · Cited by 14
Melanoma stem cells: targets for successful therapy?
Houben, R., Wischhusen, J., Menaa, F., Synwoldt, P., Schrama, D., Bröcker, E., & Becker, J. C. (2008) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2008.06786.x · Cited by 15
Yuan, X., Zhang, H., Wei, Y.-J., & Hu, S. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.05.003 · Cited by 14
Wu, C.-E., Yu, C.-W., Chang, K., Chou, W.-H., Lu, C.-Y., Ghelfi, E., Wu, F.-C., Jan, P.-S., Huang, M.-C., Allard, P., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.134 · Cited by 14
Imberti, B., Casiraghi, F., Cugini, D., Azzollini, N., Cassis, P., Todeschini, M., Solini, S., Sebastiano, V., Zuccotti, M., Garagna, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000654 · Cited by 13
Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus.
Shroff, G. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i7.223 · Cited by 14
Pilichi, S., Rocca, S., Dattena, M., Pool, R. R., Mara, L., Sanna, D., Masala, G., Manunta, M. L., Dore, S., Manunta, A., et al. (2018) · BMC Veterinary Research · doi:10.1186/s12917-018-1532-y · Cited by 13
Yang, H.-M., Moon, S., Choi, Y., Park, S., Lee, Y., Lee, H.-J., Kim, S.-J., & Chung, H. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302462 · Cited by 13
How to cross immunogenetic hurdles to human embryonic stem cell transplantation
de Rham, C., & Villard, J. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0262-z · Cited by 14
Tang, C. Z., Weissman, I. L., & Drukker, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-478-4_2 · Cited by 17
“Multiple studies have shown that MHC-I molecules are similarly expressed at low levels on human [2,3,44,45,46] and mouse [2,47,48] PSCs and increase on differentiated derivatives, albeit ultimate expression levels are lower than somatic cells.”
BackgroundSelf-citationAre cell-based therapies for kidney disease safe? A systematic review of preclinical evidence
Mihajlovic, M., Wever, K. E., van der Made, T. K., de Vries, R. B. M., Hilbrands, L. B., & Masereeuw, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.004 · Cited by 13
“Du et al., 2016 Macrophages Kidney, spleen, lung, liver Fluorescence (EGFP) Cells were mostly present in the lung and spleen 24 h post-injection and to a lower extent in the kidneys and liver.”
Mohib, K., Al-Khamees, B., Zein, H. S., Allan, D., & Wang, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032420 · Cited by 15
Current and Future Perspectives of Regenerative Medicine
Furth, M. E., & Atala, A. (2008) · Elsevier eBooks · doi:10.1016/b978-012369410-2.50003-6 · Cited by 14
Koch, K. S., Son, K., Maehr, R., Pellicciotta, I., Ploegh, H. L., Zanetti, M., Sell, S., & Leffert, H. L. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02412.x · Cited by 14
Levine, A. D. (2008) · Public Administration Review · doi:10.1111/j.1540-6210.2008.00907.x · Cited by 12
“…with adult stem cell therapies, although some evidence suggests less-developed embryonic Levine, Policy Considerations for States Supporting Stem Cell Research Preprint of an article accepted by Public Administration Review 7 cells will generate weaker immune responses (Drukker et al. 2006).”
BackgroundConversion of Embryonic Stem Cells into Pancreatic β-Cell Surrogates Guided by Ontogeny
Lees, J. G., & Tuch, B. E. (2006) · Regenerative Medicine · doi:10.2217/17460751.1.3.327 · Cited by 13
Do Cancer Stem Cells have an Immunomodulatory Role Different from the Bulk of Tumor Cells?
Ghebeh, H. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s14-003 · Cited by 12
“For example, embryonic stem cells have many signs of immune privilege [23] and are less susceptible to rejection than adult cells [24].”
BackgroundCD70–CD27 ligation between neural stem cells and CD4+ T cells induces Fas–FasL-mediated T-cell death
Lee, E. M., Hurh, S., Cho, B., Oh, K., Kim, S. U., Surh, C. D., Sprent, J., Yang, J., Kim, J. Y., & Ahn, C. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt206 · Cited by 11
“reduced MHC I expression on ESCs has been reported [29].”
BackgroundResultInfluentialChen, Y.-R., Li, Y., Chen, L., Yang, X., Su, P., & Cai, J. (2010) · Cardiovascular Pathology · doi:10.1016/j.carpath.2009.12.003 · Cited by 11
Transcriptional expression profile of cultured human embryonic stem cells in vitro and in vivo
Keil, M., Siegert, A., Eckert, K., Gerlach, J. C., Haider, W., & Fichtner, I. (2012) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-012-9487-y · Cited by 12
Kim, J., Zanjani, E. D., Jeanblanc, C. M., Goodrich, A. D., & Hematti, P. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.04.003 · Cited by 11
“Furthermore, it is postulated that hESC-derived HSCs are at a developmental stage closer to fetal HSCs [7].”
BackgroundStrategies for future histocompatible stem cell therapy
Nehlin, J. O., & Barington, T. (2009) · Biogerontology · doi:10.1007/s10522-009-9213-7 · Cited by 11
“This may turn these stem cells into targets for and stimulators of the recipients’ immune system (Drukker et al. 2006; Robertson et al. 2007).”
BackgroundInfluentialZeb, H., Khan, I. N., Munir, I., Ramadan, W. S., Ahmad, M., Hussein, D. M., Kamal, M. A., & Alkarim, S. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666161004145709 · Cited by 11
Tian, K.-W., Zhang, Y., Jiang, H., & Han, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-22867-9 · Cited by 10
Cao, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1092667 · Cited by 11
6.20 Skin Tissue Engineering ☆
Zeng, Q., Macri, L. K., Prasad, A., Clark, R. A. F., Zeugolis, D. I., Hanley, C., Garcia, Y., Pandit, A. S., Leavesley, D. I., Stupar, D., et al. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10157-2 · Cited by 18
Utermöhlen, O., & Krönke, M. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.032 · Cited by 9
Induced pluripotent stem cell technology and stem cell therapy for diabetes
Drummond, R. J., Kunath, T., Mee, P. J., & Ross, J. A. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.173 · Cited by 9
Cardiac Tissue Engineering: A Clinical Perspective
Zimmermann, W., Tiburcy, M., & Eschenhagen, T. (2007) · Future Cardiology · doi:10.2217/14796678.3.4.435 · Cited by 10
Human Stem Cells for Heart Failure Treatment
Condorelli, G., & Catalucci, D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.057 · Cited by 9
Costimulation Blockade Induces Foxp3 + Regulatory T Cells to Human Embryonic Stem Cells
Ljung, K., Simonson, O. E., Felldin, U., Wärdell, E., Ibarra, C., Antonsson, L., Kumagai‐Braesch, M., Hovatta, O., Lampela, R., Grinnemo, K., et al. (2013) · BioResearch open access · doi:10.1089/biores.2013.0039 · Cited by 8
“Initially it was reported that hESCs would not succumb to immunological rejection or they had decreased immunogenic capacity.(1) It was later demonstrated that this was not the case, and even though hESC could not function as professional antigen-presenting cells their implantation resulted in an immunological respons…”
ResultTremoleda, J. L., Khan, N. S., Mann, V., Racey, S. N., Martin, A., Simpson, H., & Noble, B. (2012) · PubMed · Cited by 11
Cardiovascular Therapeutic Aspects of Cell Therapy and Stem Cells
Gepstein, L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1380.030 · Cited by 8
At Home among Strangers: Is It Possible to Create Hypoimmunogenic Pluripotent Stem Cell Lines?
Bogomiakova, M. E., Валерьевич, Е. А., & Lagarkova, M. A. (2019) · Molecular Biology · doi:10.1134/s0026893319050042 · Cited by 8
Immunogenicity and Immune-Modulating Properties of Human Stem Cells
Nehlin, J. O., Isa, A., & Baringto, T. (2011) · InTech eBooks · doi:10.5772/17868 · Cited by 8
“…could perhaps be used in regenerative transplantation protocols. hESC have limited antigen presentation capacity because of low MHC class I cell surface expression levels and the complete lack of MHC class II molecules and co-stimulatory molecules (Drukker et al., 2006; Grinnemo et al., 2006).”
InfluentialThe Use of Cellular Technologies in Treatment of Liver Pathologies
Petrakova, O. S., Степановна, Ч. Е., Terskikh, V. V., Kalistratova, E. N., & Vasiliev, A. V. (2012) · Acta Naturae · doi:10.32607/20758251-2012-4-3-16-30 · Cited by 9
Hübscher, D., Kaiser, D., Elsner, L., Monecke, S., Dressel, R., & Guan, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00067 · Cited by 7
“In addition to T lymphocytes (23, 26), natural killer (NK) cells play an important role in the rejection of stem cell grafts (20–22, 27, 28).”
BackgroundThe Global HLA Banking of Embryonic Stem Cells Requires Further Scientific Justification
Master, Z., & Williams–Jones, B. (2007) · The American Journal of Bioethics · doi:10.1080/15265160701465361 · Cited by 7
“Although levels of major histocompatability complex (MHC) class I expression on hESCs are sufficient for immune recognition, the immunostimulatory properties of hESCs and their differentiated cell types is low compared with that of adult cells, suggesting that allograft rejection of hESCs may be significantly reduced…”
BackgroundInfluentialStem cells for myocardial repair
Caspi, O., & Gepstein, L. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul031 · Cited by 7
Induction of Pluripotent Stem Cells from Umbilical Cord Blood
Hu, K., & Slukvin, I. I. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200006 · Cited by 7
Liu, C., Wang, X., Huang, W., Meng, W., Su, Z., Xing, Q., Shi, H., Zhang, D., Zhou, M., Zhao, Y., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02427-1 · Cited by 6
Oh, M., Lee, S., Lee, G., Kim, C., Song, J. H., Yu, B. Y., & Chung, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300476 · Cited by 6
A simple culture method for epithelial stem cells derived from human hair follicle
Hilmi, A. B. M., Halim, A. S., Noor, N., Lim, C., Idris, Z., Pohchi, A., Asma, H., Wahab, S. F. A., Tiede, S., & Paus, R. (2013) · Open Life Sciences · doi:10.2478/s11535-013-0149-6 · Cited by 7
Current Thoughts on the Therapeutic Potential of Stem Cell
Rameshwar, P. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-815-3_1 · Cited by 6
Tanaka, Y., Nakamura, S., Shibata, H., Kishi, Y., Ikeda, T., Masuda, S., Sasaki, K., Abe, T., Hayashi, S., Kitano, Y., et al. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0119 · Cited by 6
“The low reactivity to ES and graft cells as compared to cynomolgus PBMCs might be a reflection of low immunogenicity of ES cells and their progeny [34,36].”
InfluentialTissue Engineering for Stem Cell Mediated Regenerative Medicine
Zoldan, J., Kraehenbuehl, T. P., Lytton‐Jean, A. K. R., Langer, R., & Anderson, D. G. (2010) · Wiley eBooks · doi:10.1002/9780470889909.ch31 · Cited by 5
Towards Personalized Cell-Replacement Therapies for Brain Repair
Lavdas, A. Α., & Matsas, R. (2009) · Personalized Medicine · doi:10.2217/pme.09.4 · Cited by 5
Stem Cells in the Reproductive System
Kyurkchiev, S., Gandolfi, F., Hayrabedyan, S., Brevini, T. A. L., Dimitrov, R., Fitzgerald, J. S., Asma, J., Mourdjeva, M., Photini, S. M., Spencer, P., et al. (2012) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2012.01140.x · Cited by 7
Morton, D. G., Alden, C. L., Bartholomew, P. M., Kreeger, J. M., & Morton, L. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415759-0.00027-3 · Cited by 5
Embryonic Stem Cell Biology: Insights from Molecular Imaging
Sallam, K., & Wu, J. C. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-705-1_12 · Cited by 5
Indirect immune recognition of mouse embryonic stem cell–derived hematopoietic progenitors in vitro
Thompson, H. L., McLelland, B. T., & Manilay, J. O. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.01.003 · Cited by 5
GMP-Compliant Perinatal Tissue-Derived Stem Cells
Arjmand, B., Goodarzi, P., Falahzadeh, K., Aghayan, H. R., Rahim, F., Mohamadi-Jahani, F., & Larijani, B. A. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-46410-7_9 · Cited by 5
Kamatani, T., Kimura, R., Ikeda, S., Inoue, M., & Seino, K.-I. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413398122 · Cited by 4
“In addition, several in vitro experiments have reported immune - privileged characteristics of PSCs, such as low MHC expression and expression of immunosuppressive factors, such as Arg1 and MFG - E8, in mouse and human ESCs ( 18 – 20 ).”
The Immunogenicity of Embryonic Stem Cells and Their Differentiated Progeny
Pearl, J. I., & Wu, J. C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5480-9_2 · Cited by 4
Lu, Y., Su, Z., Li, Y., Luo, J., Tan, Z., Ji, H., Zhu, W., Yu, G., Chen, L., & Zhang, M. (2010) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60068-0 · Cited by 4
“However, previous research demonstrates that ES cells have a low immunostimulatory potency, which fails to elicit an immune response in immunocompetent mice during the first 48 h after intramuscular injection (Li et al., 2004; Drukker et al., 2006).”
“Свой среди чужих”: можно ли создать гипоиммуногенные линии плюрипотентных стволовых клеток?
Bogomiakova, M. E., Валерьевич, Е. А., & Lagarkova, M. A. (2019) · Molecular Biology · doi:10.1134/s0026898419050045 · Cited by 4
Immunity of embryonic stem cell-derived hematopoietic progenitor cells
Zavazava, N. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0273-9 · Cited by 4
“Although MHC expression by ES cells has not been extensively studied in the literature, more recent data uniformly show that mouse and human ES cells poorly express MHC class I antigens and class II molecules [2, 11, 12].”
BackgroundAn Update on the Therapeutic Potential of Stem Cells
Rameshwar, P., Moore, C. A., Shah, N. N., & Smith, C. P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8697-2_1 · Cited by 4
Cell-derived Secretome for the Treatment of Renal Disease
Kim, M. W., Ko, I. K., Atala, A., & Yoo, J. J. (2019) · Journal of the Korean Society of Pediatric Nephrology · doi:10.3339/jkspn.2019.23.2.67 · Cited by 4
Sato, M., Aoki, H., Nakamura, T., Onodera, S., Yamaguchi, A., Saitô, A., & Azuma, T. (2020) · Journal of Periodontal Research · doi:10.1111/jre.12762 · Cited by 6
Specific Protein Markers for Stem Cell Cross-Talk with Neighboring Cells in the Environment
Park, K. S., Shin, S. W., Choi, J., & Um, S. H. (2013) · International Journal of Stem Cells · doi:10.15283/ijsc.2013.6.2.75 · Cited by 4
Leshansky, L., Aberdam, D., Itskovitz‐Eldor, J., & Berrih‐Aknin, S. (2014) · Stem Cells · doi:10.1002/stem.1833 · Cited by 4
Fetal Pancreas as a Source for Islet Transplantation
Eventov‐Friedman, S., & Reisner, Y. (2013) · Diabetes · doi:10.2337/db13-0018 · Cited by 4
“Further, it has been demonstrated that even embryonic (13) or mesenchymal (14) stem cells cannot evade rejection.”
BackgroundSelf-citationIslet Cell Therapy and Pancreatic Stem Cells
Domínguez‐Bendala, J., Pileggi, A., & Ricordi, C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10023-9 · Cited by 4
Stem Cells and Nanotechnology in Tissue Engineering and Regenerative Medicine
Bean, A., & Tuan, R. S. (2013) · Wiley eBooks · doi:10.1002/9781118574775.ch1 · Cited by 6
Stem‐Cell‐Based Small‐Diameter Blood Vessels with 3D Printing
Wang, Y., Wang, X., Chen, J., Wallace, G. G., & Gu, Q. (2024) · Small Science · doi:10.1002/smsc.202400261 · Cited by 4
Metadata
- Authors
- Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., & Benvenisty, N.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Weizmann Institute of Science (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
- Corresponding author
- Drukker, Micha
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-18
- Volume
- 24
- Issue
- 2
- Pages
- 221-229
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2006712783
- Cited by
- 402
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 16 · 2017: 15 · 2016: 12 · 2015: 21 · 2014: 19 · 2013: 30 · 2012: 34
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- human embryonic stem cells, immune rejection, xenotransplantation, allorejection, T cell response, cytotoxic T lymphocytes, MHC class I, immunodeficient mice, immunocompetent mice, cell therapy, immunosuppression
- MeSH terms
- Animals, Cell Differentiation, Embryo, Mammalian, Graft Rejection, Humans, Immunocompetence, Membrane Glycoproteins, Mice, Inbred Strains, Mice, Mutant Strains, Stem Cells, T-Lymphocytes, Cytotoxic, Transplantation, Heterologous, T-Lymphocyte Subsets, Mice, SCID, Gene Expression Profiling, Stem Cell Transplantation, Tumor Necrosis Factors, Mice, Fas Ligand Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.